PanTher Therapeutics
PrivateLast Round
Grant
May 20, 2026
Total Funding Raised
$38.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PanTher Therapeutics operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Grant round in May 2026.
PanTher Therapeutics is a clinical-stage oncology company that develops a proprietary platform for continuous, high-dose, localized treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanTher Therapeutics Comparables
Compare PanTher Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alessa Therapeutics, Inc. | 85% | |
| Continuity Biosciences | 82% | |
| RenovoRx | 80% |
For institutional investors. Book with your work email.
PanTher Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2026 | ||||
| Series B | Apr 4, 2025 | ||||
| Convertible Debt | Dec 18, 2023 | ||||
| Series A Extension | Dec 16, 2022 | ||||
| Grant | Aug 17, 2022 | ||||
Series A Extension | Jun 24, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PanTher Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention & Research Institute of Texas | Grant |
| MedTech Innovator | Grant |
| Massachusetts Life Sciences Center | Grant |
| Catalyst Health Ventures | Series A Extension, Series A, Series B |
| Angel Physicians Fund | Series A, Series A Extension, Series B |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 60% MoM, reaching 2.7K.
- May 20, 2026
$1.77M grant from Cancer Prevention and Research Institute of Texas
For institutional investors. Book with your work email.
PanTher Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PanTher Therapeutics's valuation, stock price, and market status.
Is PanTher Therapeutics a public or private company?
PanTher Therapeutics is a private company.
What is the current stock price of PanTher Therapeutics?
PanTher Therapeutics is a private company, so its shares have no public market price. Caplight tracks PanTher Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PanTher Therapeutics worth (valuation)?
Valuation information for PanTher Therapeutics is not publicly available.
Can I buy PanTher Therapeutics stock?
PanTher Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PanTher Therapeutics's last funding round?
PanTher Therapeutics's most recent funding round was Grant on May 20, 2026.
Who are the main investors in PanTher Therapeutics?
Key investors in PanTher Therapeutics include Catalyst Health Ventures, Angel Physicians Fund.
Will PanTher Therapeutics IPO soon?
No public IPO plans have been announced for PanTher Therapeutics.
How can I track PanTher Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PanTher Therapeutics's shares on secondary markets.